Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Further, previous studies involving various ethnic groups have revealed associations between COPD and genetic polymorphisms in families with sequence similarity 13, member A (FAM13A), micro-RNA 2054 (MIR2054), SET domain containing protein 7 (SETD7), ring finger protein 150 (RNF150), hedgehog interacting protein (HHIP), and vascular endothelial growth factor A (VEGFA).
|
26251585 |
2015 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.
|
22080838 |
2012 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.
|
30804561 |
2019 |
Chronic Obstructive Airway Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Cellular localization of FAM13A protein and mRNA levels of FAM13A in COPD lungs were assessed using immunofluorescence, Western blotting, and reverse transcriptase-polymerase chain reaction, respectively.
|
26862784 |
2016 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Cumulative genetic risk score analyses (CGRS), derived by adding risk alleles, revealed that the risk for COPD increased with the growing number of the FAM13A risk alleles.
|
26310313 |
2015 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
We performed lung gene expression profiling of two different wild-type murine strains (C57BL/6 and NZW/LacJ) and two genetic models with mutations in COPD genome-wide association study genes (HHIP and FAM13A) after 6 months of chronic CS exposure and compared the results to human COPD lung tissues.
|
28248572 |
2017 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Variants in FAM13A are associated with chronic obstructive pulmonary disease.
|
20173748 |
2010 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.
|
25101718 |
2015 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Analysis of 6633 individuals with moderate to severe COPD and 5704 control individuals confirmed association at three known loci: CHRNA3 (p=6·38 × 10(-14)), FAM13A (p=1·12 × 10(-14)), and HHIP (p=1·57 × 10(-12)).
|
24621683 |
2014 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to investigate whether FAM13A polymorphisms would be associated with COPD susceptibility and COPD-related phenotypes in a Chinese Han population.
|
23891779 |
2013 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
CTD_human |
We noted two loci shared with pulmonary fibrosis (FAM13A and DSP) but that had opposite risk alleles for COPD.
|
28166215 |
2017 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Family with sequence similarity 13 member A (FAM13A) has been previously associated with lung function in several lung diseases, including chronic obstructive pulmonary disease, asthma, lung cancer, and pulmonary fibrosis.
|
30604588 |
2019 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Variants in FAM13A have been found in genome-wide association studies (GWAS) to associate with lung function in the general population as well as in several common chronic lung diseases (CLD) such as chronic obstructive pulmonary disease (COPD), asthma, as well as in idiopathic interstitial pneumonias (IIP).
|
25163686 |
2014 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
rs17014601 in FAM13A was significantly associated with COPD in the additive (odds ratio [OR]=1.36, 95% confidence interval [CI]: 1.11-1.67, <i>P</i>=0.003), heterozygote (OR=1.76, 95% CI: 1.33-2.32, <i>P</i>=0.0001), and dominant (OR=1.67, 95% CI: 1.28-2.18, <i>P</i>=0.0001) models.
|
29872291 |
2018 |
Chronic Obstructive Airway Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we provide a framework that integrates the existing human interactome information with experimental protein-protein interaction data for FAM13A, one of the most highly associated genetic loci to COPD, to find a more comprehensive disease network module.
|
30262855 |
2018 |
Chronic Obstructive Airway Disease
|
0.500 |
Biomarker
|
disease |
CTD_human |
Variants in FAM13A are associated with chronic obstructive pulmonary disease.
|
20173748 |
2010 |
Pulmonary Fibrosis
|
0.440 |
Biomarker
|
disease |
BEFREE |
Family with sequence similarity 13 member A (FAM13A) has been previously associated with lung function in several lung diseases, including chronic obstructive pulmonary disease, asthma, lung cancer, and pulmonary fibrosis.
|
30604588 |
2019 |
Pulmonary Fibrosis
|
0.440 |
Biomarker
|
disease |
HPO |
|
|
|
Pulmonary Fibrosis
|
0.440 |
Biomarker
|
disease |
CTD_human |
We noted two loci shared with pulmonary fibrosis (FAM13A and DSP) but that had opposite risk alleles for COPD.
|
28166215 |
2017 |
Pulmonary Fibrosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
We noted two loci shared with pulmonary fibrosis (FAM13A and DSP) but that had opposite risk alleles for COPD.
|
28166215 |
2017 |
Pulmonary Fibrosis
|
0.440 |
Biomarker
|
disease |
BEFREE |
The expression of FAM13A and miR-328 was measured in PF rats, and gain- and loss-of-function assays were conducted to determine the regulatory effects of FAM13A and miR-328 on PF.
|
31164635 |
2019 |
Pulmonary Fibrosis
|
0.440 |
GeneticVariation
|
disease |
BEFREE |
Two recent genome-wide association studies (GWASs) reported that the FAM13A gene at the 4q22 locus associated with pulmonary fibrosis (defined by rs2609255) overlapping with COPD (defined by rs6837671).
|
29621588 |
2018 |
Hamman-Rich syndrome
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
|
23583980 |
2013 |
Chronic Airflow Obstruction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Variants in FAM13A are associated with chronic obstructive pulmonary disease.
|
20173748 |
2010 |
Chronic Airflow Obstruction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.
|
28166215 |
2017 |